Evolutionary Genomics Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
4
- Stock Symbol
-
FNAM
- Investments
-
1
Evolutionary Genomics General Information
Description
Evolutionary Genomics Inc is involved in the development of a technology platform, the Adapted Traits Platform (ATP), to identify commercially valuable genes that control important traits in animals and plants. It uses the ATP to identify genes to improve crop plant traits such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. The company's platform identifies key genes that have changed successfully to impart new or improved traits. Its primary source of revenue had been contract services revenue for research performed by it on behalf of other commercial entities and grant income received from governmental agencies, industry associations and grant-making foundations for research performed.
Contact Information
Website
www.evolgen.comCorporate Office
- 1026 Anaconda Drive
- Castle Rock, CO 80108
- United States
Corporate Office
- 1026 Anaconda Drive
- Castle Rock, CO 80108
- United States
Evolutionary Genomics Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 1K |
Evolutionary Genomics Financials Summary
As of 31-Dec-2022, Evolutionary Genomics has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Dec-2022 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 12,276 | 11,840 | ||
| Revenue | 0 | 0 | 0 | 12 |
| EBITDA | (913) | (913) | (1,755) | (2,290) |
| Net Income | (1,935) | (1,935) | (2,794) | (1,712) |
| Total Assets | 2,354 | 2,354 | 2,932 | 3,993 |
| Total Debt | 3,744 | 3,744 | 3,744 | 2,246 |
Evolutionary Genomics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Evolutionary Genomics Comparisons
Industry
Financing
Details
Evolutionary Genomics Competitors (2)
One of Evolutionary Genomics’s 2 competitors is Syngenta, a Formerly Accelerator/Incubator backed company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Syngenta | Formerly Accelerator/Incubator backed | Basel, Switzerland | ||||
| Bayer CropScience United States | Formerly VC-backed | Whippany, NJ |
Evolutionary Genomics Signals
Evolutionary Genomics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Evolutionary Genomics Acquisitions (1)
Evolutionary Genomics’s most recent deal was a Merger/Acquisition with Fona. The deal was made on 19-Oct-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Fona | 19-Oct-2015 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Evolutionary Genomics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Diversified Financials
Industry
Rank
Percentile
Consumer Finance
Subindustry
Rank
Percentile
Evolutionary Genomics FAQs
-
When was Evolutionary Genomics founded?
Evolutionary Genomics was founded in 2000.
-
Where is Evolutionary Genomics headquartered?
Evolutionary Genomics is headquartered in Castle Rock, CO.
-
What is the size of Evolutionary Genomics?
Evolutionary Genomics has 4 total employees.
-
What industry is Evolutionary Genomics in?
Evolutionary Genomics’s primary industry is Media and Information Services (B2B).
-
Is Evolutionary Genomics a private or public company?
Evolutionary Genomics is a Public company.
-
What is Evolutionary Genomics’s stock symbol?
The ticker symbol for Evolutionary Genomics is FNAM.
-
Who are Evolutionary Genomics’s competitors?
Syngenta and Bayer CropScience United States are competitors of Evolutionary Genomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process